Charité Centrum für Neurologie, Neurochirurgie und Psychiatrie

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS	Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder	Recruiting	Phase 2	2026-07-23		NCT07142291

Clinical trials